Rearranged ent-kauranes from the stems of Tricalysia dubia and their biological activities

Journal of Natural Medicines

Volumn 62, Issue 3, 2008, Pages 314-320

  Tamaki, Naoko ^a   Matsunami, Katsuyoshi ^a   Otsuka, Hideaki ^a   Shinzato, Takakazu ^b   Aramoto, Mitsunori ^b   Takeda, Yoshio ^c  

^a HIROSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Cytotoxicity; K562 Adr; P glycoprotein; Rearranged ent kaurane; Rubiaceae; Tricalysia dubia

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOPROTEIN P; TRICALYSIA DUBIA EXTRACT;

ARTICLE; BIOLOGICAL ACTIVITY; CARBON NUCLEAR MAGNETIC RESONANCE; CELL STRAIN KB; CONTROLLED STUDY; CYTOTOXICITY; DRUG DETERMINATION; DRUG INHIBITION; ELECTROSPRAY; HETERONUCLEAR MULTIPLE BOND CORRELATION; HUMAN; HUMAN CELL; PLANT STEM; PROTON NUCLEAR MAGNETIC RESONANCE; TRICALYSIA DUBIA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DITERPENES, KAURANE; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HUMANS; K562 CELLS; KB CELLS; P-GLYCOPROTEIN; PLANT EXTRACTS; PLANT STEMS; RUBIACEAE; SPECTRUM ANALYSIS;

EID: 44949166469     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-008-0248-x     Document Type: Article

References (15)

1. Hatusima S (1975) Flora of the Ryukyus, added and corrected. The Biological Society of Okinawa, Naha, p 577
2. He D-H, Otsuka H, Hirata E, Shinzato T, Bando M, Takeda Y (2002) Tricalysiosides A-G: rearranged ent-kauranoid glycosides from the leaves of Tricalysia dubia. J Nat Prod 65:685-688
3. He D-H, Matsunami K, Otsuka H, Hirata E, Shinzato T, Aramoto M, Bando M, Takeda Y (2005) Tricalysiosides H-O: ent-kaurane glucosides from the leaves of Tricalysia dubia. Phytochemistry 66:2857-2864
4. Nishimura K, Hitotsuyanagi Y, Sugeta N, Sakakura K, Fujita K, Fukuya H, Aoyagi Y, Hasuda T, Kinoshita T, He D-H, Otsuka H, Takeda Y, Takeya K (2006) Tricalysiolides A-F, new rearranged ent-kaurane diterpenes from Tricalysia dubia. Tetrahedron 62:1512-1519
5. He D-H, Matsunami K, Otsuka H, Shinzato T, Aramoto M, Bando M, Takeda Y (2007) Tricalysiolide G and tricalysiols A and B: rearranged ent-kaurane-type and ent-kaurane-type diterpenoids from the leaves of Tricalysia dubia (Lindl.) Ohwi. J Nat Med 61:46-50
6. Della Greca M, Monaco P, Previtera L (1990) Stigmasterols from Typha latifolia. J Nat Prod 53:1430-1435
7. Xie LH, Akao T, Hamasaki K, Deyama T, Hattori M (2003) Biotransformation of pinoresinol diglucoside to mammalian lignans by human intestinal microflora, and isolation of Enterococcus faecalis strain PDG-1 responsible for the transformation of (+)-pinoresinol to (+)-lariciresinol. Chem Pharm Bull (Tokyo) 51:508-515
8. Vasconcelos JMJ, Silva AMS, Cavaleiro JAS (1998) Chromones and flavanones from Artemisia campestris subsp. maritima. Phytochemistry 49:1421-1424
9. 13C-NMR chemical shifts for monomeric lignin model compounds. J Mol Struct 505:257-267
10. Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152-162
11. Bosch I, Croop J (1996) P-glycoprotein multidrug resistance and cancer. Biochim Biophys Acta 1288:F37-F54
12. Stähelin H (1973) Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors. Eur J Cancer 9:215-221
13. Nissen NI, Hansen HH, Pederson H, Stroyer I, Dombernowsky P, Hessllund M (1975) Clinical trial of the oral form of a new podophyllotoxin derivative, VP-16-213 (NSC-141540), in patients with advanced neoplastic disease. Cancer Chemother Rep 59:1027-1029
14. Issell BF, Crooke ST (1979) Etoposide (VP-16-213). Cancer Treat Rev 6:107-124
15. Tsuruo T, Lida H, Tsukagoshi S, Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967-1972